Feeds › 8-K events
8-K events
Major news companies must report to the SEC: results, deals, leadership changes.
About this data
- What it is
- A Form 8-K is how a public company announces major news between its quarterly reports: earnings, an acquisition, a new CEO, a cybersecurity incident. Each filing lists the numbered items it covers.
- Who files it
- The company, usually within four business days of the event.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Many 8-Ks are routine, so the item description is the place to start. Item 9.01, which only lists attached documents, is hidden unless you ask for it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
8-K items filed per day, last 30 days
All items Earnings results (2.02)
One filing can report several items. Item 9.01, which only lists attached documents, is not counted.
Latest 8-K filings
Showing: ticker ZBIO
| Filed | Company | Item | Form | Filing |
|---|---|---|---|---|
| Nov 6, 2026 | ZBIO Zenas BioPharma, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Nov 5, 2026 | ZBIO Zenas BioPharma, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Oct 13, 2026 | ZBIO Zenas BioPharma, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Aug 13, 2026 | ZBIO Zenas BioPharma, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Aug 13, 2026 | ZBIO Zenas BioPharma, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| May 13, 2026 | ZBIO Zenas BioPharma, Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| May 13, 2026 | ZBIO Zenas BioPharma, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| May 13, 2026 | ZBIO Zenas BioPharma, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Mar 31, 2026 | ZBIO Zenas BioPharma, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Mar 31, 2026 | ZBIO Zenas BioPharma, Inc. | 2.03 Creation of a Direct Financial Obligation | 8-K | 8-K ↗ |
| Mar 31, 2026 | ZBIO Zenas BioPharma, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Mar 16, 2026 | ZBIO Zenas BioPharma, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Feb 13, 2026 | ZBIO Zenas BioPharma, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Jan 5, 2026 | ZBIO Zenas BioPharma, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Jan 5, 2026 | ZBIO Zenas BioPharma, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jan 5, 2026 | ZBIO Zenas BioPharma, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Dec 15, 2025 | ZBIO Zenas BioPharma, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Nov 12, 2025 | ZBIO Zenas BioPharma, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Oct 27, 2025 | ZBIO Zenas BioPharma, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Oct 27, 2025 | ZBIO Zenas BioPharma, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Oct 8, 2025 | ZBIO Zenas BioPharma, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Oct 8, 2025 | ZBIO Zenas BioPharma, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Oct 8, 2025 | ZBIO Zenas BioPharma, Inc. | 3.02 Unregistered Sales of Equity Securities | 8-K | 8-K ↗ |
| Oct 8, 2025 | ZBIO Zenas BioPharma, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Oct 8, 2025 | ZBIO Zenas BioPharma, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Sep 2, 2025 | ZBIO Zenas BioPharma, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Sep 2, 2025 | ZBIO Zenas BioPharma, Inc. | 2.03 Creation of a Direct Financial Obligation | 8-K | 8-K ↗ |
| Sep 2, 2025 | ZBIO Zenas BioPharma, Inc. | 2.01 Completion of Acquisition or Disposition of Assets | 8-K | 8-K ↗ |
| Sep 2, 2025 | ZBIO Zenas BioPharma, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Aug 12, 2025 | ZBIO Zenas BioPharma, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jun 12, 2025 | ZBIO Zenas BioPharma, Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| Jun 12, 2025 | ZBIO Zenas BioPharma, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Jun 4, 2025 | ZBIO Zenas BioPharma, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| May 15, 2025 | ZBIO Zenas BioPharma, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Feb 5, 2025 | ZBIO Zenas BioPharma, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Dec 2, 2024 | ZBIO Zenas BioPharma, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Nov 12, 2024 | ZBIO Zenas BioPharma, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
37 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 6:27 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances